MedPath

Investigation of a New 1-piece Convex Ostomy Product

Not Applicable
Completed
Conditions
Stoma Ileostomy
Stoma Colostomy
Registration Number
NCT02043782
Lead Sponsor
Coloplast A/S
Brief Summary

The aim of the investigation was to investigate the performance and safety of a new ostomy product

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
38
Inclusion Criteria
  • Are at least 18 years of age and have full legal capacity.
  • Have had an ileostomy/colostomy for more than 3 months
  • Have used a 1-piece flat ostomy product for the last 1 month
  • Has given written Informed Consent and signed the letter of authority
  • Have an ileostomy or colostomy with a diameter of 33 mm or less
  • Has experienced leakage (seeping) under the baseplate at least three times during the last two weeks
  • Are evaluated to be suitable for a soft convex product
  • If having a colostomy: changes their product on average 2 times pr. 24h or more
  • Currently uses a bag of size medi/midi or maxi
Exclusion Criteria
  • Have a loop ostomy (also called double-barrel or ostomy with two outlets).
  • Are pregnant or breastfeeding
  • Currently receiving or have within the past 2 month received radio- and/or chemotherapy
  • Currently receiving or have within the past month received systemic or local steroid treatment in the peristomal area
  • Currently suffering from peristomal skin problems (i.e. bleeding or broken skin).
  • Known hypersensitivity toward any of the test products
  • Participating in other interventional clinical investigations or have previously participated in this investigation
  • Use irrigation during the investigation (flush the intestine with water)
  • Have a fistula in the peristomal area or less than 2 cm from the edge of the baseplate
  • If subject has a colostomy: empties the bag

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Degree of Leakage14 +/- 3 days

The degree of leakage is investigated on a 32-point scale (including 0 for no leakage). O represents no leakage and 32 represents the worst leakage.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

TFS

🇩🇰

Søborg, Denmark

TFS
🇩🇰Søborg, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.